About this opportunity: Freenome is approaching FDA approval and commercial launch of SimpleScreen™, our cfDNA-based colorectal cancer detection test.
As we cross that milestone, we need a dedicated owner for the postmarket quality infrastructure that commercial launch demands — someone who can build and run a complain
Full posting locked
Company, description, requirements, and direct apply unlock with a subscription.